chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Echocardiogram, Electrocardiogram, Pericarditis
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422890. A 21-year-old male patient received ACAM2000 (lot number VV04003A) on 29 April 2011. On 07 May 2011, 8 days post-vaccination, the patient developed acute pericarditis. An EKG and echocardiogram were performed; results were not reported. The patient had no illness at the time of vaccination, and no relevant medical history. He was hospitalized, and subsequently recovered on an unspecified date. Documents held by sender: None.
Age: 23.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Erythema, Fatigue, Oropharyngeal pain, Pyrexia, Rash maculo-papular
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422949. A 23-year-old female patient received the following vaccinations on 02 May 2011: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number E03021), anthrax (manufacturer not reported, lot number FAV274). Nine days prior to vaccination, the patient had undergone oral surgery to remove 4 wisdom teeth, and was taking MOTRIN and PERCOCET concomitantly following oral surgery. Additional concomitant medication included NORINYL 1/35-28. On 12 May 2011, 10 days post-vaccination, the patient developed extensive erythematous maculopapular lesions on the abdomen, thighs, and legs. She was seen in the emergency room and by dermatology; by the following day, she had developed erythematous lesions on the neck, arms and hands. She was seen in the clinic with complaints of a sore throat, light fever, and feeling tired; rapid strep test was negative. Treatment included CLARITIN, ZYRTEC, ATARAX, and BENADRYL. Of note, the case narrative has "smallpox, tetanus, and anthrax" listed as the vaccines received on 02 May 2011; however, the coded vaccines are smallpox, typhoid, and anthrax. Coding has been left per VAERS entry.
Age: 23.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Skin lesion, Streptococcus test, Streptococcus test negative
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422949. A 23-year-old female patient received the following vaccinations on 02 May 2011: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number E03021), anthrax (manufacturer not reported, lot number FAV274). Nine days prior to vaccination, the patient had undergone oral surgery to remove 4 wisdom teeth, and was taking MOTRIN and PERCOCET concomitantly following oral surgery. Additional concomitant medication included NORINYL 1/35-28. On 12 May 2011, 10 days post-vaccination, the patient developed extensive erythematous maculopapular lesions on the abdomen, thighs, and legs. She was seen in the emergency room and by dermatology; by the following day, she had developed erythematous lesions on the neck, arms and hands. She was seen in the clinic with complaints of a sore throat, light fever, and feeling tired; rapid strep test was negative. Treatment included CLARITIN, ZYRTEC, ATARAX, and BENADRYL. Of note, the case narrative has "smallpox, tetanus, and anthrax" listed as the vaccines received on 02 May 2011; however, the coded vaccines are smallpox, typhoid, and anthrax. Coding has been left per VAERS entry.
Age: 23.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Fatigue, Oropharyngeal pain, Pyrexia, Rash erythematous, Rash maculo-papular
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422949. A 23-year-old female patient received the following vaccinations on 02 May 2011: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number E03021), anthrax (manufacturer not reported, lot number FAV274). Nine days prior to vaccination, the patient had undergone oral surgery to remove 4 wisdom teeth, and was taking MOTRIN and PERCOCET concomitantly following oral surgery. Additional concomitant medication included NORINYL 1/35-28. On 12 May 2011, 10 days post-vaccination, the patient developed extensive erythematous maculopapular lesions on the abdomen, thighs, and legs. She was seen in the emergency room and by dermatology; by the following day, she had developed erythematous lesions on the neck, arms and hands. She was seen in the clinic with complaints of a sore throat, light fever, and feeling tired; rapid strep test was negative. Treatment included CLARITIN, ZYRTEC, ATARAX, and BENADRYL. Of note, the case narrative has "smallpox, tetanus, and anthrax" listed as the vaccines received on 02 May 2011; however, the coded vaccines are smallpox, typhoid, and anthrax. Coding has been left per VAERS entry.
Age: 23.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Streptococcus test negative
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422949. A 23-year-old female patient received the following vaccinations on 02 May 2011: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number E03021), anthrax (manufacturer not reported, lot number FAV274). Nine days prior to vaccination, the patient had undergone oral surgery to remove 4 wisdom teeth, and was taking MOTRIN and PERCOCET concomitantly following oral surgery. Additional concomitant medication included NORINYL 1/35-28. On 12 May 2011, 10 days post-vaccination, the patient developed extensive erythematous maculopapular lesions on the abdomen, thighs, and legs. She was seen in the emergency room and by dermatology; by the following day, she had developed erythematous lesions on the neck, arms and hands. She was seen in the clinic with complaints of a sore throat, light fever, and feeling tired; rapid strep test was negative. Treatment included CLARITIN, ZYRTEC, ATARAX, and BENADRYL. Of note, the case narrative has "smallpox, tetanus, and anthrax" listed as the vaccines received on 02 May 2011; however, the coded vaccines are smallpox, typhoid, and anthrax. Coding has been left per VAERS entry.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Exposure to vaccinated person, Orthopoxvirus test positive, Polymerase chain reaction, Skin lesion
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422996. A 25-year-old female patient was exposed to a male vaccinated person who received the following vaccinations on 26 April 2011: ACAM2000 (lot number not reported) and an Anthrax vaccine (manufacturer and lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the vaccinee's vaccination. The patient had no current illnesses, no medical history and took no other medications. The vaccinee's medical history was unknown. The patient was a nursing student who contacted the Department of Health (DOH) regarding a suspicious lesion on her chin. She had contact with her boyfriend, who was a contractor and was vaccinated against smallpox on 26 April 2011 by the military. The patient was with her boyfriend from 04 May 2011 through 09 May 2011 during which time the vaccinee only wore a band-aid on the site while they slept. The patient helped him change the bandage on his vaccination site on 07 May 2011 (site was red with central depression and purulent drainage). On 09 May 2011, the patient developed what she thought was a pimple on her chin. The lesion progressed and she recognized it as not being a pimple and called the DOH on 11 May 2011. On 13 May 2011, she developed 3 additional lesions on her chin. The patient required an Emergency visit. On 13 May 2011, a swab of the patient's lesion showed amplified non-variola Orthopoxvirus DNA using a real-time polymerase chain reaction (PCR) assay (Ct-18) at the lab. On 14 May 2011, the patient was treated with vaccinia immune globulin (VIG). The outcome was reported as unknown.  The reporter in this case is the same as in case 2011-05785. 02 September 2011: Upon internal review, it was determined that this case meets seriousness criteria; case has been upgraded to serious. Documents held by sender: None.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Exposure to vaccinated person, Laboratory test abnormal, Orthopoxvirus test positive, Polymerase chain reaction, Secondary transmission
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422996. A 25-year-old female patient was exposed to a male vaccinated person who received the following vaccinations on 26 April 2011: ACAM2000 (lot number not reported) and an Anthrax vaccine (manufacturer and lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the vaccinee's vaccination. The patient had no current illnesses, no medical history and took no other medications. The vaccinee's medical history was unknown. The patient was a nursing student who contacted the Department of Health (DOH) regarding a suspicious lesion on her chin. She had contact with her boyfriend, who was a contractor and was vaccinated against smallpox on 26 April 2011 by the military. The patient was with her boyfriend from 04 May 2011 through 09 May 2011 during which time the vaccinee only wore a band-aid on the site while they slept. The patient helped him change the bandage on his vaccination site on 07 May 2011 (site was red with central depression and purulent drainage). On 09 May 2011, the patient developed what she thought was a pimple on her chin. The lesion progressed and she recognized it as not being a pimple and called the DOH on 11 May 2011. On 13 May 2011, she developed 3 additional lesions on her chin. The patient required an Emergency visit. On 13 May 2011, a swab of the patient's lesion showed amplified non-variola Orthopoxvirus DNA using a real-time polymerase chain reaction (PCR) assay (Ct-18) at the lab. On 14 May 2011, the patient was treated with vaccinia immune globulin (VIG). The outcome was reported as unknown.  The reporter in this case is the same as in case 2011-05785. 02 September 2011: Upon internal review, it was determined that this case meets seriousness criteria; case has been upgraded to serious. Documents held by sender: None.
Age: 25.0
Sex: F
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Skin lesion
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 422996. A 25-year-old female patient was exposed to a male vaccinated person who received the following vaccinations on 26 April 2011: ACAM2000 (lot number not reported) and an Anthrax vaccine (manufacturer and lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the vaccinee's vaccination. The patient had no current illnesses, no medical history and took no other medications. The vaccinee's medical history was unknown. The patient was a nursing student who contacted the Department of Health (DOH) regarding a suspicious lesion on her chin. She had contact with her boyfriend, who was a contractor and was vaccinated against smallpox on 26 April 2011 by the military. The patient was with her boyfriend from 04 May 2011 through 09 May 2011 during which time the vaccinee only wore a band-aid on the site while they slept. The patient helped him change the bandage on his vaccination site on 07 May 2011 (site was red with central depression and purulent drainage). On 09 May 2011, the patient developed what she thought was a pimple on her chin. The lesion progressed and she recognized it as not being a pimple and called the DOH on 11 May 2011. On 13 May 2011, she developed 3 additional lesions on her chin. The patient required an Emergency visit. On 13 May 2011, a swab of the patient's lesion showed amplified non-variola Orthopoxvirus DNA using a real-time polymerase chain reaction (PCR) assay (Ct-18) at the lab. On 14 May 2011, the patient was treated with vaccinia immune globulin (VIG). The outcome was reported as unknown.  The reporter in this case is the same as in case 2011-05785. 02 September 2011: Upon internal review, it was determined that this case meets seriousness criteria; case has been upgraded to serious. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Injection site pain, Lymphadenopathy, Sleep disorder
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423054. A 26-year-old male patient received ACAM2000 (lot number VV04003A) and anthrax vaccine (manufacturer not reported, lot number FAV261) on 05 May 2011. On 12 May 2011, 7 days post-vaccination, the patient was awoken from sleep with complaints of lymphadenopathy of the left axilla and vaccine site pain in the left deltoid. He had no loss of the use of his arm, and did not miss any work. He was advised to follow-up with his provider as needed for increased symptoms. Recovery as unknown.
Age: 26.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Lymphadenopathy, Sleep disorder, Vaccination site pain
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423054. A 26-year-old male patient received ACAM2000 (lot number VV04003A) and anthrax vaccine (manufacturer not reported, lot number FAV261) on 05 May 2011. On 12 May 2011, 7 days post-vaccination, the patient was awoken from sleep with complaints of lymphadenopathy of the left axilla and vaccine site pain in the left deltoid. He had no loss of the use of his arm, and did not miss any work. He was advised to follow-up with his provider as needed for increased symptoms. Recovery as unknown.
Age: 21.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, ANTH, JEV1, SMALL
Symptoms: Erythema, Lymph node pain, Lymphadenopathy, Oedema peripheral, Rash erythematous
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423331. A 21-year-old male patient received ACAM2000 (lot number VV04003A), BIOTHRAX (lot number FAV261), and IXIARO (lot number JEV09L36A) on 25 April 2011. On 10 May 2011, 25 days post-vaccination, the patient developed an erythematous papular rash, swollen erythematous hands, and tender enlarged cervical nodes (per the reporter, "the axillary nodes enlarged earlier and resolved, this is not considered an adverse reaction). Of note, the patient had a severe sunburn two months prior to vaccination, and had experienced peeling of his arms. The patient presented to the emergency room, and subsequently recovered on an unspecified date.
Age: 21.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, ANTH, JEV1, SMALL
Symptoms: Rash papular
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423331. A 21-year-old male patient received ACAM2000 (lot number VV04003A), BIOTHRAX (lot number FAV261), and IXIARO (lot number JEV09L36A) on 25 April 2011. On 10 May 2011, 25 days post-vaccination, the patient developed an erythematous papular rash, swollen erythematous hands, and tender enlarged cervical nodes (per the reporter, "the axillary nodes enlarged earlier and resolved, this is not considered an adverse reaction). Of note, the patient had a severe sunburn two months prior to vaccination, and had experienced peeling of his arms. The patient presented to the emergency room, and subsequently recovered on an unspecified date.
Age: 21.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, ANTH, JEV1, SMALL
Symptoms: Erythema, Lymph node pain, Lymphadenopathy, Oedema peripheral, Rash papular
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423331. A 21-year-old male patient received ACAM2000 (lot number VV04003A), BIOTHRAX (lot number FAV261), and IXIARO (lot number JEV09L36A) on 25 April 2011. On 10 May 2011, 25 days post-vaccination, the patient developed an erythematous papular rash, swollen erythematous hands, and tender enlarged cervical nodes (per the reporter, "the axillary nodes enlarged earlier and resolved, this is not considered an adverse reaction). Of note, the patient had a severe sunburn two months prior to vaccination, and had experienced peeling of his arms. The patient presented to the emergency room, and subsequently recovered on an unspecified date.
Age: 25.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Chest X-ray, Cough, Dyspnoea, Orthopnoea, Pulmonary function test
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423454. A 25-year-old female patient with a history of exercise-induced asthma received ACAM2000 (lot number VV04003A) on 13 May 2010. Concomitant medications included TOPAMAX, birth control, and albuterol MDI. On 22 May 2010, 9 days post-vaccination, the patient developed shortness of breath at night with difficulty breathing when lying down. On 24 May 2010 symptoms progressed to difficulty breathing, slight fever, and cough. She underwent 2 pulmonary function tests and a chest x-ray; results were not reported. The patient subsequently recovered on an unspecified date.
Age: 25.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Pyrexia
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423454. A 25-year-old female patient with a history of exercise-induced asthma received ACAM2000 (lot number VV04003A) on 13 May 2010. Concomitant medications included TOPAMAX, birth control, and albuterol MDI. On 22 May 2010, 9 days post-vaccination, the patient developed shortness of breath at night with difficulty breathing when lying down. On 24 May 2010 symptoms progressed to difficulty breathing, slight fever, and cough. She underwent 2 pulmonary function tests and a chest x-ray; results were not reported. The patient subsequently recovered on an unspecified date.
Age: 25.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Cough, Dyspnoea, Pyrexia
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423454. A 25-year-old female patient with a history of exercise-induced asthma received ACAM2000 (lot number VV04003A) on 13 May 2010. Concomitant medications included TOPAMAX, birth control, and albuterol MDI. On 22 May 2010, 9 days post-vaccination, the patient developed shortness of breath at night with difficulty breathing when lying down. On 24 May 2010 symptoms progressed to difficulty breathing, slight fever, and cough. She underwent 2 pulmonary function tests and a chest x-ray; results were not reported. The patient subsequently recovered on an unspecified date.
Age: 27.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Oedema peripheral, Skin lesion
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 423889. A 27-year-old male patient received ACAM2000 (lot number not reported) and anthrax vaccine (unknown manufacturer) on 05 March 2010. On 10 March 2010, 5 days post-vaccination, the patient developed leg swelling and skin lesions on the body. The patient had no illness at the time of vaccination, and no relevant medical history. He was hospitalized, and outcome was reported as "not recovered". Documents held by sender: None.
Age: 38.0
Sex: M
Vaccine: SMALL, TDAP, SMALL, TDAP
Symptoms: Chest X-ray abnormal, Coagulation factor V level normal, Coagulation factor level normal, Computerised tomogram abnormal, Cytogenetic analysis normal
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 424223. A 38 year-old male patient had received the following vaccinations on 11 January 2011: a left arm injection of ACAM2000 (lot number VV04003A), and a fourth dose intramuscular right arm injection of ADACEL (lot number C3382AA). On 03 February 2011, the patient experienced dyspnea went to the clinic and underwent a chest x-ray (which was abnormal). It was thought at that time the patient had pneumonia and was prescribed antibiotics. A week later the patient began to spit up blood and he went to the ER (emergency department). The patient had an abnormal CAT scan that revealed thrombosis and a pulmonary infarct. Treatment included WARFARIN therapy until September. The patient had a prolongation of hospitalization (dates not reported). Laboratory results included a normal coagulation factor V level, a normal coagulation factor level and a normal cytogenetic analysis. No further information was available at the time of the report. The patient's outcome was reported as life threatening, not recovered and disabled. Documents held by sender: none.
Age: 38.0
Sex: M
Vaccine: SMALL, TDAP, SMALL, TDAP
Symptoms: Dyspnoea, Haemoptysis, Pulmonary infarction, Thrombosis
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 424223. A 38 year-old male patient had received the following vaccinations on 11 January 2011: a left arm injection of ACAM2000 (lot number VV04003A), and a fourth dose intramuscular right arm injection of ADACEL (lot number C3382AA). On 03 February 2011, the patient experienced dyspnea went to the clinic and underwent a chest x-ray (which was abnormal). It was thought at that time the patient had pneumonia and was prescribed antibiotics. A week later the patient began to spit up blood and he went to the ER (emergency department). The patient had an abnormal CAT scan that revealed thrombosis and a pulmonary infarct. Treatment included WARFARIN therapy until September. The patient had a prolongation of hospitalization (dates not reported). Laboratory results included a normal coagulation factor V level, a normal coagulation factor level and a normal cytogenetic analysis. No further information was available at the time of the report. The patient's outcome was reported as life threatening, not recovered and disabled. Documents held by sender: none.
Age: 38.0
Sex: M
Vaccine: SMALL, TDAP, SMALL, TDAP
Symptoms: Dyspnoea, Haematemesis, Pulmonary infarction, Thrombosis
Clinical narrative: This case was received on 21 July 2011 via a third party query tool search on the VAERS database, under reference number 424223. A 38 year-old male patient had received the following vaccinations on 11 January 2011: a left arm injection of ACAM2000 (lot number VV04003A), and a fourth dose intramuscular right arm injection of ADACEL (lot number C3382AA). On 03 February 2011, the patient experienced dyspnea went to the clinic and underwent a chest x-ray (which was abnormal). It was thought at that time the patient had pneumonia and was prescribed antibiotics. A week later the patient began to spit up blood and he went to the ER (emergency department). The patient had an abnormal CAT scan that revealed thrombosis and a pulmonary infarct. Treatment included WARFARIN therapy until September. The patient had a prolongation of hospitalization (dates not reported). Laboratory results included a normal coagulation factor V level, a normal coagulation factor level and a normal cytogenetic analysis. No further information was available at the time of the report. The patient's outcome was reported as life threatening, not recovered and disabled. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Accidental exposure
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424477. A 20-year-old male patient received the following vaccination on 20 May 2011: a left arm ACAM2000 (SP Biologics Co. lot number VV04003ACA), and an intramuscular right arm BIOTHRAX (EMERGENT lot number SAV281). The patient had no current illnesses. The patient's medical history and concomitant medications were not reported. On 01 June 2011, the patient had an inadvertent inoculation of the left arm which required an Emergency visit. The outcome was reported as recovered. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Post vaccination autoinoculation
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424477. A 20-year-old male patient received the following vaccination on 20 May 2011: a left arm ACAM2000 (SP Biologics Co. lot number VV04003ACA), and an intramuscular right arm BIOTHRAX (EMERGENT lot number SAV281). The patient had no current illnesses. The patient's medical history and concomitant medications were not reported. On 01 June 2011, the patient had an inadvertent inoculation of the left arm which required an Emergency visit. The outcome was reported as recovered. Documents held by sender: None.
Age: 35.0
Sex: M
Vaccine: ANTH, FLU3, SMALL, TYP, ANTH, FLU3, SMALL, TYP
Symptoms: Hypoaesthesia, Intervertebral disc protrusion, Muscular weakness, Nuclear magnetic resonance imaging abnormal, Ulnar nerve palsy
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424759. A 35-year-old male patient received the following vaccination on 25 October 2010: a left arm ACAM2000 (lot number VV04003A), an intramuscular dose 2 intramuscular right arm TYPHIM VI (lot number D1087), a right arm (dose 1) anthrax (Michigan DPH, lot number FAV251) and an intramuscular right arm AFLURIA (CSL Limited, lot number 09949111B). The patient had no medical history, no illness at the time of vaccination and took no concomitant medications. The patient denied any problems with previous vaccinations. The patient had developed hypoaesthesia, intervertebral disc protrusion, muscular weakness and ulnar nerve palsy. Later that night he began to experience numbness in his 4/5th fingers. The patient required an Emergency visit. He sought medical evaluation on 04 November 2010 and was given Nonsteroidal Anti-inflammatory Drugs (NSAIDS). He had follow-up visits in December, January, February and March for persistent numbness and left upper extremity weakness. He had no relief from an ulnar splint. His cervical magnetic resonance imaging (MRI) revealed a mild disc bulge but no canal narrowing. On 11 April 2011, he was evaluated by neurosurgery and underwent a repeat MRI. Per neuro, there was no evidence of a compressive neuropathy at the level of the C-spine. Neuro stated that his leading hypothesis was that this was some immune modulated idiosyncratic reaction and assessed as having non progressive subacute left ulnar nerve palsy. He was released with no limitations and was given a trial of a MEDROL dose pack. He was seen for follow-up on 13 May 2011 where he reported that he still had some numbness to his hand and the provider stated that left upper extremity (LUE) weakness appeared to be resolving and his strength had significantly improved from the last encounter. The outcome was reported as unknown. Documents held by sender: None.
Age: 35.0
Sex: M
Vaccine: ANTH, FLU3, SMALL, TYP, ANTH, FLU3, SMALL, TYP
Symptoms: Hypoaesthesia, Immune system disorder, Intervertebral disc protrusion, Muscular weakness, Nuclear magnetic resonance imaging spinal cord abnormal
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424759. A 35-year-old male patient received the following vaccination on 25 October 2010: a left arm ACAM2000 (lot number VV04003A), an intramuscular dose 2 intramuscular right arm TYPHIM VI (lot number D1087), a right arm (dose 1) anthrax (Michigan DPH, lot number FAV251) and an intramuscular right arm AFLURIA (CSL Limited, lot number 09949111B). The patient had no medical history, no illness at the time of vaccination and took no concomitant medications. The patient denied any problems with previous vaccinations. The patient had developed hypoaesthesia, intervertebral disc protrusion, muscular weakness and ulnar nerve palsy. Later that night he began to experience numbness in his 4/5th fingers. The patient required an Emergency visit. He sought medical evaluation on 04 November 2010 and was given Nonsteroidal Anti-inflammatory Drugs (NSAIDS). He had follow-up visits in December, January, February and March for persistent numbness and left upper extremity weakness. He had no relief from an ulnar splint. His cervical magnetic resonance imaging (MRI) revealed a mild disc bulge but no canal narrowing. On 11 April 2011, he was evaluated by neurosurgery and underwent a repeat MRI. Per neuro, there was no evidence of a compressive neuropathy at the level of the C-spine. Neuro stated that his leading hypothesis was that this was some immune modulated idiosyncratic reaction and assessed as having non progressive subacute left ulnar nerve palsy. He was released with no limitations and was given a trial of a MEDROL dose pack. He was seen for follow-up on 13 May 2011 where he reported that he still had some numbness to his hand and the provider stated that left upper extremity (LUE) weakness appeared to be resolving and his strength had significantly improved from the last encounter. The outcome was reported as unknown. Documents held by sender: None.
Age: 35.0
Sex: M
Vaccine: ANTH, FLU3, SMALL, TYP, ANTH, FLU3, SMALL, TYP
Symptoms: Splint application, Ulnar nerve palsy
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424759. A 35-year-old male patient received the following vaccination on 25 October 2010: a left arm ACAM2000 (lot number VV04003A), an intramuscular dose 2 intramuscular right arm TYPHIM VI (lot number D1087), a right arm (dose 1) anthrax (Michigan DPH, lot number FAV251) and an intramuscular right arm AFLURIA (CSL Limited, lot number 09949111B). The patient had no medical history, no illness at the time of vaccination and took no concomitant medications. The patient denied any problems with previous vaccinations. The patient had developed hypoaesthesia, intervertebral disc protrusion, muscular weakness and ulnar nerve palsy. Later that night he began to experience numbness in his 4/5th fingers. The patient required an Emergency visit. He sought medical evaluation on 04 November 2010 and was given Nonsteroidal Anti-inflammatory Drugs (NSAIDS). He had follow-up visits in December, January, February and March for persistent numbness and left upper extremity weakness. He had no relief from an ulnar splint. His cervical magnetic resonance imaging (MRI) revealed a mild disc bulge but no canal narrowing. On 11 April 2011, he was evaluated by neurosurgery and underwent a repeat MRI. Per neuro, there was no evidence of a compressive neuropathy at the level of the C-spine. Neuro stated that his leading hypothesis was that this was some immune modulated idiosyncratic reaction and assessed as having non progressive subacute left ulnar nerve palsy. He was released with no limitations and was given a trial of a MEDROL dose pack. He was seen for follow-up on 13 May 2011 where he reported that he still had some numbness to his hand and the provider stated that left upper extremity (LUE) weakness appeared to be resolving and his strength had significantly improved from the last encounter. The outcome was reported as unknown. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, JEV1, SMALL, ANTH, JEV1, SMALL
Symptoms: Rash erythematous, Sinusitis, Urticaria
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424867. A 21-year-old male patient received the following vaccinations on 23 May 2011: a right arm ACAM2000 (SP Biologics Co. lot number VV04003A), left arm BIOTHRAX, (EMERGENT, lot number FAV273), and left arm IXIARO (INTERCELL, lot number JEV09L36A). On 27 May 2011, the patient was diagnosed with sinusitis and was treated with amoxicillin and CLARITIN. On 02 June 2011, the patient developed red dots and hives on upper arms. On 03 June 2011, there was an increase in rash up to 1 inch above elbow which was non-vesicular and non-umbilicated. On 05 June 2011, it spread to the lower body. The patient required an Emergency visit. He was evaluated by a physician who diagnosed the patient with urticarial reaction most likely secondary to (2/2) delayed drug reaction (amoxicillin). No laboratory testing was performed. The outcome was reported as recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, JEV1, SMALL, ANTH, JEV1, SMALL
Symptoms: Adverse drug reaction, Injection site rash, Rash, Rash erythematous, Sinusitis
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424867. A 21-year-old male patient received the following vaccinations on 23 May 2011: a right arm ACAM2000 (SP Biologics Co. lot number VV04003A), left arm BIOTHRAX, (EMERGENT, lot number FAV273), and left arm IXIARO (INTERCELL, lot number JEV09L36A). On 27 May 2011, the patient was diagnosed with sinusitis and was treated with amoxicillin and CLARITIN. On 02 June 2011, the patient developed red dots and hives on upper arms. On 03 June 2011, there was an increase in rash up to 1 inch above elbow which was non-vesicular and non-umbilicated. On 05 June 2011, it spread to the lower body. The patient required an Emergency visit. He was evaluated by a physician who diagnosed the patient with urticarial reaction most likely secondary to (2/2) delayed drug reaction (amoxicillin). No laboratory testing was performed. The outcome was reported as recovered. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, JEV1, SMALL, JEV1, SMALL, ANTH, JEV1, SMALL
Symptoms: Urticaria
Clinical narrative: This case was received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424867. A 21-year-old male patient received the following vaccinations on 23 May 2011: a right arm ACAM2000 (SP Biologics Co. lot number VV04003A), left arm BIOTHRAX, (EMERGENT, lot number FAV273), and left arm IXIARO (INTERCELL, lot number JEV09L36A). On 27 May 2011, the patient was diagnosed with sinusitis and was treated with amoxicillin and CLARITIN. On 02 June 2011, the patient developed red dots and hives on upper arms. On 03 June 2011, there was an increase in rash up to 1 inch above elbow which was non-vesicular and non-umbilicated. On 05 June 2011, it spread to the lower body. The patient required an Emergency visit. He was evaluated by a physician who diagnosed the patient with urticarial reaction most likely secondary to (2/2) delayed drug reaction (amoxicillin). No laboratory testing was performed. The outcome was reported as recovered. Documents held by sender: None.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Body temperature fluctuation, Cardiac enzymes increased, Chest X-ray normal, Chest pain, Computerised tomogram normal
Clinical narrative: This case was received on 27 May 2011 from agency under agency tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59)). Treatment medications included: ZOFRAN, TORADOL, ASA, NITROPASTE, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. NOTE: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Follow-up information received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424970. VAERS reported additional coded events of body temperature fluctuation, chest pain, cough, and dyspnoea. Onset/stop dates were not reported. Additional events coded by VAERS were cardiac enzyme increased, chest X-ray normal, computerised tomogram normal, electrocardiogram normal, Troponin I increased, and Fibrin D dimer, which were previously reported and added to this case in the laboratory section. Recovery status for the patient was reported as "recovered". Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Cough, Dyspnoea, Electrocardiogram normal, Fibrin D dimer, Myocarditis
Clinical narrative: This case was received on 27 May 2011 from agency under agency tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59)). Treatment medications included: ZOFRAN, TORADOL, ASA, NITROPASTE, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. NOTE: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Follow-up information received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424970. VAERS reported additional coded events of body temperature fluctuation, chest pain, cough, and dyspnoea. Onset/stop dates were not reported. Additional events coded by VAERS were cardiac enzyme increased, chest X-ray normal, computerised tomogram normal, electrocardiogram normal, Troponin I increased, and Fibrin D dimer, which were previously reported and added to this case in the laboratory section. Recovery status for the patient was reported as "recovered". Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Pericarditis, Troponin I increased
Clinical narrative: This case was received on 27 May 2011 from agency under agency tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59)). Treatment medications included: ZOFRAN, TORADOL, ASA, NITROPASTE, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. NOTE: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Follow-up information received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424970. VAERS reported additional coded events of body temperature fluctuation, chest pain, cough, and dyspnoea. Onset/stop dates were not reported. Additional events coded by VAERS were cardiac enzyme increased, chest X-ray normal, computerised tomogram normal, electrocardiogram normal, Troponin I increased, and Fibrin D dimer, which were previously reported and added to this case in the laboratory section. Recovery status for the patient was reported as "recovered". Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Body temperature fluctuation, Cardiac enzymes increased, Chest X-ray normal, Chest pain, Computerised tomogram thorax normal
Clinical narrative: This case was received on 27 May 2011 from agency under agency tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59)). Treatment medications included: ZOFRAN, TORADOL, ASA, NITROPASTE, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. NOTE: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Follow-up information received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424970. VAERS reported additional coded events of body temperature fluctuation, chest pain, cough, and dyspnoea. Onset/stop dates were not reported. Additional events coded by VAERS were cardiac enzyme increased, chest X-ray normal, computerised tomogram normal, electrocardiogram normal, Troponin I increased, and Fibrin D dimer, which were previously reported and added to this case in the laboratory section. Recovery status for the patient was reported as "recovered". Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Cough, Dyspnoea, Electrocardiogram normal, Fibrin D dimer increased, Myocarditis
Clinical narrative: This case was received on 27 May 2011 from agency under agency tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59)). Treatment medications included: ZOFRAN, TORADOL, ASA, NITROPASTE, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. NOTE: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Follow-up information received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424970. VAERS reported additional coded events of body temperature fluctuation, chest pain, cough, and dyspnoea. Onset/stop dates were not reported. Additional events coded by VAERS were cardiac enzyme increased, chest X-ray normal, computerised tomogram normal, electrocardiogram normal, Troponin I increased, and Fibrin D dimer, which were previously reported and added to this case in the laboratory section. Recovery status for the patient was reported as "recovered". Documents held by sender: none.
Sex: M
Vaccine: SMALL, SMALL, SMALL
Symptoms: Painful respiration, Pericarditis, Troponin I increased
Clinical narrative: This case was received on 27 May 2011 from agency under agency tracking number FDA-15 (No VAERS). A male patient in his twenties had received in 2011 ACAM2000 (lot number and exact date of administration not reported), and 11 days post vaccination presented to the ER (emergency room) with mild upper chest pain for two days, especially with deep breath. On examination he was found to have shortness of breath, some coughing and body temperature changes. He was hospitalized for two days (dates not reported). Laboratory and diagnostic findings included: EKG, CXR (chest x-ray) and chest CT negative; elevated enzymes; elevated Troponin I (11 days post vaccination 0.44 and 12 days post vaccination 0.58); Fibrin D-dimer (12 days post vaccination 0.62 (0.00-0.59)). Treatment medications included: ZOFRAN, TORADOL, ASA, NITROPASTE, LOVENOX and MOTRIN. The patient's chest pain resolved and was diagnosed with myocarditis or pericarditis. The patient was released without limitations. NOTE: Although the manufacturer was not reported in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. Follow-up information received on 24 August 2011 via a third party query tool search on the VAERS database, under reference number 424970. VAERS reported additional coded events of body temperature fluctuation, chest pain, cough, and dyspnoea. Onset/stop dates were not reported. Additional events coded by VAERS were cardiac enzyme increased, chest X-ray normal, computerised tomogram normal, electrocardiogram normal, Troponin I increased, and Fibrin D dimer, which were previously reported and added to this case in the laboratory section. Recovery status for the patient was reported as "recovered". Documents held by sender: none.